OxySight for MolecuLightDX+
MolecuLight, Inc. · Decision date Nov 5, 2026
What did the FDA decide?
The FDA record for K262858 lists OxySight for MolecuLightDX+ from MolecuLight, Inc. (Toronto, Canada) under product code MUD, specialty Cardiovascular, as a Traditional 510(k) received 08/13/2026. The decision recorded is SESE, dated 11/05/2026, which for a 510(k) denotes clearance rather than PMA approval. The record does not describe the device's components, intended use, or what, if anything, changed relative to a prior clearance.
The same listing shows a summary document for this submission, but the excerpt provided does not include its contents, so the specific device description and any comparison to a predicate remain unknown. The Cardiovascular specialty and MUD product code are as recorded in the source; no clinical performance, indications, or labeling conclusions can be drawn from these fields alone. The related entries for K262842 and K262864 are separate submissions by other applicants and are not part of this decision.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Cardiovascular
- Decision date
- Nov 5, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K262858
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- MolecuLight, Inc.
- Product code
- MUD
- Decision code
- SESE
- Decision date
- Nov 5, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Oximeter, Tissue Saturation.
- Applicant
- MolecuLight, Inc.
- Product code
- MUD
- FDA device class
- 2
FDA decision timeline
K262858 received
Application receipt date recorded by FDA.
K262858 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
No additional submissions with a verified PMA or product-code relationship are linked here.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
MolecuLight, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Toronto
Sources and methodology
- Original FDA record: K262858
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records